Agilent Presents Boehringer Ingelheim With Inaugural 2025 Instrument Trade‑In Impact Award Agilent Technologies Inc. today announced that Boehringer Ingelheim has been selected as the winner of Agilent’s inaugural Instrument Trade‑In Impact Award, recognizing exceptional sustainability leadership demonstrated through their participation in…
New ZOLL Zenix Monitor/Defibrillator Receives MDR Approval ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that Zenix®, the company’s most clinically advanced and easy-to-use professional monitor/defibrillator, is approved under the European Union (EU)…
1,600+ Pharmacies Using EQUIPP Copilot™ Report Up to 4x Revenue Boost, Close More Care Gaps Pharmacy Quality Solutions (PQS), an Innovaccer company and leader in pharmacy-payer performance technology, today announced significant adoption and early outcomes from EQUIPP Copilot™, the industry’s…
AOP Health US, LLC Awarded Pharmaceutical Agreement With Premier, Inc. AOP Health US, LLC has been awarded a Pharmaceutical national group purchasing agreement with Premier, Inc. Effective August 1, 2025, the agreement allows Premier members, at their discretion, to take…
Vida Health Expands Cardiometabolic Care to Include MASH, Addressing a Fast-Growing Obesity-Related Cost Driver Vida Health, a virtual, personalized obesity care provider that helps patients manage obesity, diabetes, and related conditions, today announced the expansion of its clinical portfolio to…
MedImpact Offers Humira Biosimilar 95% Below the Cost of Humira to Any Hospital or Pharmacy MedImpact Holdings, Inc. today announced the launch of an unbranded biosimilar to Humira® (adalimumab) priced at 95% below the brand-name cost. MedImpact is offering this…
VideaHealth and Aspen Dental Launch One of Dentistry’s Largest AI Rollouts in Record Time, Redefining Patient Care Nationwide VideaHealth, the leading dental AI platform, and Aspen Dental Management, Inc., one of the nation’s largest and fastest-growing dental support organizations, today…
Butterfly Network Achieves GovRAMP and TX-RAMP Information Security Certifications Butterfly Network, Inc. a digital health company transforming care with semiconductor chip-based ultrasound devices, software and AI, today announced that its Butterfly iQ+/iQ3 and Compass AI™ ultrasound solution have achieved GovRAMP…
Coya Therapeutics to Host Webinar with Leading Medical Experts on Amyotrophic Lateral Sclerosis (ALS) Drug Development, Patient Landscape, and Ongoing Clinical Trial Coya Therapeutics, Inc a clinical-stage biotechnology company developing biologics intended to enhance T-cell (Treg) function in patients with…
Innovate 32 Partners with Trivette Osborne & Associates, Expanding its Dental Services Presence in Tennessee Innovate 32 a rapidly expanding, partner-driven dental services organization, announced its partnership with Trivette Osborne & Associates, DDS, PLLC (“T&O”), a leading provider of comprehensive…
Estrella Immunopharma Presents Promising Updated Data on EB103 in Oral Presentation at the 2026 Tandem Meetings of ASTCT® & CIBMTR® Estrella Immunopharma, Inc. (Nasdaq: ESLA, ESLAW) a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS® T-cell therapies to treat cancer and autoimmune…
VectorY Therapeutics Announces First Participant Dosed in Phase 1/2 PIONEER-ALS Clinical Trial of VTx-002 in People with Amyotrophic Lateral Sclerosis (ALS) VectorY Therapeutics, a leader in vectorized antibody therapies for neurodegenerative diseases, announced today that the first participant has been…
